7T Brain MRS in HIV Infection: Correlation with Cognitive Impairment and Performance on Neuropsychological Tests

BACKGROUND AND PURPOSE: Validated neuroimaging markers of HIV-associated neurocognitive disorder in patients on antiretroviral therapy are urgently needed for clinical trials. The purpose of this study was to explore the relationship between cognitive impairment and brain metabolism in older subjects with HIV infection. It was hypothesized that MR spectroscopy measurements related to neuronal health and function (particularly N-acetylaspartate and glutamate) would be lower in HIV-positive subjects with worse cognitive performance. MATERIALS AND METHODS: Forty-five HIV-positive patients (mean age, 58.9 ± 5.3 years; 33 men) underwent detailed neuropsychological testing and brain MR spectroscopy at 7T. Twenty-four subjects were classified as having asymptomatic cognitive impairment, and 21 were classified as having symptomatic cognitive impairment. Single-voxel proton MR spectra were acquired from 5 brain regions and quantified using LCModel software. Brain metabolites and neuropsychological test results were compared using nonparametric statistics and Pearson correlation coefficients. RESULTS: Differences in brain metabolites were found between symptomatic and asymptomatic subjects, with the main findings being lower measures of N-acetylaspartate in the frontal white matter, posterior cingulate cortex, and precuneus. In the precuneus, glutamate was also lower in the symptomatic group. In the frontal white matter, precuneus, and posterior cingulate cortex, NAA and glutamate measurements showed significant positive correlation with better performance on neuropsychological tests. CONCLUSIONS: Compared with asymptomatic subjects, symptomatic HIV-positive subjects had lower levels of NAA and glutamate, most notably in the frontal white matter, which also correlated with performance on neuropsychological tests. High-field MR spectroscopy offers insight into the pathophysiology associated with cognitive impairment in HIV and may be useful as a quantitative outcome measure in future treatment trials.

[1]  L. Radloff.  The use of the Center for Epidemiologic Studies Depression Scale in adolescents and young adults , 1991, Journal of youth and adolescence.

[2]  D. Menon,et al.  Proton MR Spectroscopy of the Brain in AIDS Dementia Complex , 1992, Journal of computer assisted tomography.

[3]  S. Provencher.  Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.

[4]  I. Wilkinson,et al.  Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic, and MR imaging findings. , 1993, Radiology.

[5]  G. Fein,et al.  N-acetylaspartate reductions measured by 1H MRSI in cognitively impaired HIV-seropositive individuals. , 1994, Magnetic resonance imaging.

[6]  P. Barker,et al.  AIDS dementia complex: evaluation with proton MR spectroscopic imaging. , 1995, Radiology.

[7]  J. Hennig,et al.  HIV-related metabolic abnormalities in the brain: depiction with proton MR spectroscopy with short echo times. , 1996, Radiology.

[8]  J. Catalan,et al.  Cerebral proton magnetic resonance spectroscopy in asymptomatic HIV infection , 1997, AIDS.

[9]  P. V. van Zijl,et al.  Magnetic Resonance Spectroscopy and Spectroscopic Imaging for the Study of Brain Metabolism a , 1997, Annals of the New York Academy of Sciences.

[10]  J. Brandt,et al.  Construct and concurrent validity of the Hopkins Verbal Learning Test-revised. , 1999, The Clinical neuropsychologist.

[11]  L. Chang,et al.  Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia , 1999, Neurology.

[12]  P. Pezzotti,et al.  Inter-rater reliability of a modified Karnofsky Scale of Performance Status for HIV-infected individuals. , 1999, AIDS patient care and STDs.

[13]  P. Barker,et al.  Single‐voxel proton MRS of the human brain at 1.5T and 3.0T , 2001, Magnetic resonance in medicine.

[14]  K. Marder,et al.  Clinical trials in HIV-associated cognitive impairment: Cognitive and functional outcomes , 2001, Neurology.

[15]  Linda Chang,et al.  Relationships among Brain Metabolites, Cognitive Function, and Viral Loads in Antiretroviral-Naı̈ve HIV Patients , 2002, NeuroImage.

[16]  W. Schlote,et al.  HIV‐Related Neuropathology, 1985 to 1999: Rising Prevalence of HIV Encephalopathy in the Era of Highly Active Antiretroviral Therapy , 2002, Journal of acquired immune deficiency syndromes.

[17]  L. Chang,et al.  Increased frontal white matter diffusion is associated with glial metabolites and psychomotor slowing in HIV , 2004, Journal of Neuroimmunology.

[18]  O. Selnes,et al.  Higher frequency of dementia in older HIV-1 individuals , 2004, Neurology.

[19]  Linda Chang,et al.  Antiretroviral Treatment Alters Relationship between Mcp-1 and Neurometabolites in HIV Patients , 2003, Antiviral therapy.

[20]  T. Ernst,et al.  A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age , 2004, NeuroImage.

[21]  I. Grant,et al.  Test-Retest Reliability of Component Process Variables Within the Hopkins Verbal Learning Test-Revised , 2005, Assessment.

[22]  R. Benedict,et al.  Semantic Clustering Indexes for the Hopkins Verbal Learning Test�Revised: Initial Exploration in Elder Control and Dementia Groups , 2006, Applied neuropsychology.

[23]  Linda Chang,et al.  Proton MRS and neuropsychological correlates in AIDS dementia complex: evidence of subcortical specificity. , 2007, The Journal of neuropsychiatry and clinical neurosciences.

[24]  J. Becker,et al.  Updated research nosology for HIV-associated neurocognitive disorders , 2007, Neurology.

[25]  I. Grant,et al.  Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. , 2008, Archives of neurology.

[26]  Rolf Gruetter,et al.  MR spectroscopy of the human brain with enhanced signal intensity at ultrashort echo times on a clinical platform at 3T and 7T , 2009, Magnetic resonance in medicine.

[27]  B. Ross,et al.  Evidence of reduced glutamate in the frontal lobe of HIV‐seropositive patients , 2009, NMR in biomedicine.

[28]  K. Uğurbil,et al.  In vivo 1H NMR spectroscopy of the human brain at high magnetic fields: Metabolite quantification at 4T vs. 7T , 2009, Magnetic resonance in medicine.

[29]  B. Navia,et al.  The AIDS dementia complex: Clinical and basic Neuroscience with implications for novel molecular therapies , 2005, Neurotoxicity Research.

[30]  Yaakov Stern,et al.  Food combination and Alzheimer disease risk: a protective diet. , 2010, Archives of neurology.

[31]  M. Gill,et al.  Neurologic disease burden in treated HIV/AIDS predicts survival , 2010, Neurology.

[32]  E. Halpern,et al.  Factor analysis of proton MR spectroscopic imaging data in HIV infection: metabolite-derived factors help identify infection and dementia. , 2010, Radiology.

[33]  J. McArthur,et al.  Human immunodeficiency virus‐associated neurocognitive disorders: Mind the gap , 2010, Annals of neurology.

[34]  Linda Chang,et al.  Lower brain glutamate is associated with cognitive deficits in HIV patients: A new mechanism for HIV‐associated neurocognitive disorder , 2010, Journal of magnetic resonance imaging : JMRI.

[35]  O. Selnes,et al.  Brain metabolism and cognitive impairment in HIV infection: a 3-T magnetic resonance spectroscopy study. , 2010, Magnetic resonance imaging.

[36]  P. Pronyk,et al.  The Impact of Highly Active Antiretroviral Therapy on Activities of Daily Living in HIV-Infected Adults in South Africa , 2011, AIDS and Behavior.

[37]  E Mark Haacke,et al.  Correlation of putative iron content as represented by changes in R2* and phase with age in deep gray matter of healthy adults , 2010, Journal of magnetic resonance imaging : JMRI.

[38]  J. Neuhaus,et al.  The Effects of Age and HIV on Neuropsychological Performance , 2010, Journal of the International Neuropsychological Society.

[39]  Eric S. Rosenberg,et al.  Alterations in brain metabolism during the first year of HIV infection , 2011, Journal of NeuroVirology.

[40]  Gülin Öz,et al.  Short‐echo, single‐shot, full‐intensity proton magnetic resonance spectroscopy for neurochemical profiling at 4 T: Validation in the cerebellum and brainstem , 2011, Magnetic resonance in medicine.

[41]  E. Halpern,et al.  Exploring the relationship of macrophage colony-stimulating factor levels on neuroaxonal metabolism and cognition during chronic human immunodeficiency virus infection , 2010, Journal of NeuroVirology.

[42]  O. Selnes,et al.  A comparison of performance-based measures of function in HIV-associated neurocognitive disorders , 2011, Journal of NeuroVirology.

[43]  S. Francis,et al.  Applications of multi-nuclear magnetic resonance spectroscopy at 7T. , 2011, World journal of radiology.

[44]  Jianhui Zhong,et al.  Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment , 2011, AIDS.

[45]  Jintanat Ananworanich,et al.  Change in Brain Magnetic Resonance Spectroscopy after Treatment during Acute HIV Infection , 2012, PloS one.

[46]  M. Gallagher,et al.  Age-Related Memory Impairment Is Associated with Disrupted Multivariate Epigenetic Coordination in the Hippocampus , 2012, PloS one.

[47]  L. Ferrucci,et al.  Correspondence between in vivo 11C-PiB-PET amyloid imaging and postmortem, region-matched assessment of plaques , 2012, Acta Neuropathologica.

[48]  Peter B Barker,et al.  Reproducibility of brain spectroscopy at 7T using conventional localization and spectral editing techniques , 2013, Journal of magnetic resonance imaging : JMRI.

[49]  Ana M. Daugherty,et al.  Age-related differences in iron content of subcortical nuclei observed in vivo: A meta-analysis , 2013, NeuroImage.

[50]  A. Dale,et al.  What is normal in normal aging? Effects of aging, amyloid and Alzheimer's disease on the cerebral cortex and the hippocampus , 2014, Progress in Neurobiology.

[51]  P. Rapp,et al.  Reassessing the effects of histone deacetylase inhibitors on hippocampal memory and cognitive aging , 2014, Hippocampus.

[52]  C. Yiannoutsos,et al.  Cerebral metabolite changes prior to and after antiretroviral therapy in primary HIV infection , 2014, Neurology.

[53]  Peter B Barker,et al.  Comparison of single voxel brain MRS AT 3T and 7T using 32-channel head coils. , 2015, Magnetic resonance imaging.

[54]  Yi Wang,et al.  Age and sex related differences in subcortical brain iron concentrations among healthy adults , 2015, NeuroImage.

[55]  R. Paul,et al.  Neuronal-Glia Markers by Magnetic Resonance Spectroscopy in HIV Before and After Combination Antiretroviral Therapy , 2016, Journal of acquired immune deficiency syndromes.

[56]  D. Montaldi,et al.  The newly revised interview for deteriorations in daily living activities in dementia (R-IDDD2): distinguishing initiative from performance at assessment , 2016, International Psychogeriatrics.

[57]  P. Belchior,et al.  Critical appraisal of questionnaires to assess functional impairment in individuals with mild cognitive impairment , 2016, International Psychogeriatrics.

[58]  B. Brew,et al.  HIV-associated neurocognitive disorder. , 2018, Handbook of clinical neurology.